机构:[1]Department of Medical Oncology, The First Affiliated Hospital of Traditional Chinese Medicine University, Guangzhou, Guangdong, People’s Republic of China[2]Department of Medical Oncology, Cancer Center of Sun Yat-sen University, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, People’s Republic of China[3]Department of Medical Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, People’s Republic of China中山大学附属第一医院[4]Department of Pathology, Cancer Center of Sun Yat-sen University, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, People’s Republic of China[5]Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, People’s Republic of China中山大学附属第一医院[6]Department of Medical Oncology, Sun Yat-sen University Cancer Center, 651 Dong Feng Road East, Guangzhou 510060, People’s Republic of China
Non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue (MALT) type arises from a wide variety of extranodal sites, most frequently from the gastrointestinal tract. Recently, it has been demonstrated that karyotypic alterations involving the PIK3CA and FOXP1 genes of chromosome 3 occur in MALT lymphoma. However, their associated protein expression has not been extensively studied. Tumor tissues from 27 gastric and 23 intestinal MALT lymphomas were analyzed for PIK3CA and FOXP1 protein expression using immunohistochemistry and correlated with histological features and treatment outcomes. Expression of PIK3CA, a novel indicator, was found in 40% of gastrointestinal cases and indicated an inferior progression-free survival in both gastric and intestinal MALT lymphomas (P = 0.001 and P = 0.015). Tumor staining of nuclear FOXP1 (46.0%) was more common in gastric than intestinal MALT lymphomas (P = 0.042) and was significantly associated with polymorphic histology (P = 0.007). FOXP1 expression was identified as an adverse prognostic factor for overall survival in gastric MALT lymphomas (P = 0.035). We further combined these two markers and observed that patients that are positive for both PIK3CA and FOXP1 had a worse overall and progression-free survival. Considering the small sample size of this study, these results should be confirmed in a large prospective study.
基金:
Guangdong National Science grant
05200178, Guangdong Science and Technology program
2003C30314, and Guangzhou Science grant 2006Z3-E0021.
第一作者机构:[1]Department of Medical Oncology, The First Affiliated Hospital of Traditional Chinese Medicine University, Guangzhou, Guangdong, People’s Republic of China[2]Department of Medical Oncology, Cancer Center of Sun Yat-sen University, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, People’s Republic of China
共同第一作者:
通讯作者:
通讯机构:[2]Department of Medical Oncology, Cancer Center of Sun Yat-sen University, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, People’s Republic of China[6]Department of Medical Oncology, Sun Yat-sen University Cancer Center, 651 Dong Feng Road East, Guangzhou 510060, People’s Republic of China
推荐引用方式(GB/T 7714):
Zhai Linzhu,Zhao Yuanyuan,Ye Sheng,et al.Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type.[J].TUMOR BIOLOGY.2011,32(5):913-920.doi:10.1007/s13277-011-0192-3.
APA:
Zhai Linzhu,Zhao Yuanyuan,Ye Sheng,Huang He,Tian Ying...&Lin Tongyu.(2011).Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type..TUMOR BIOLOGY,32,(5)
MLA:
Zhai Linzhu,et al."Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type.".TUMOR BIOLOGY 32..5(2011):913-920